Nemaura Medical Inc
(NMRD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2023 | 03-2022 | 03-2021 | 03-2020 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,144 | -13,887 | -6,259 | -4,160 | -4,453 |
| Depreciation Amortization | 1,424 | 230 | 98 | 55 | 33 |
| Accounts receivable | 1,022 | -250 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 190 | -117 | -40 | 139 | 98 |
| Other Working Capital | -2,054 | -175 | -1,958 | 78 | 394 |
| Other Operating Activity | 5,110 | 7,695 | 2,161 | 440 | 366 |
| Operating Cash Flow | $-8,452 | $-6,504 | $-5,998 | $-3,450 | $-3,561 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -539 | -957 | -836 | -211 | -80 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 4,484 |
| Investing Cash Flow | $-539 | $-957 | $-836 | $-211 | $4,404 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 25,000 | N/A | N/A |
| Debt Repayment | 4,700 | N/A | -1,525 | N/A | N/A |
| Common Stock Issued | 8,394 | 6,083 | 16,151 | 179 | 2,539 |
| Other Financing Activity | -11,012 | -12,451 | -1,640 | -81 | -489 |
| Financing Cash Flow | $2,082 | $-6,368 | $37,986 | $97 | $2,050 |
| Exchange Rate Effect | -735 | -287 | 607 | -71 | 26 |
| Beginning Cash Position | 17,749 | 31,865 | 106 | 3,741 | 822 |
| End Cash Position | 10,105 | 17,749 | 31,865 | 106 | 3,741 |
| Net Cash Flow | $-7,644 | $-14,116 | $31,759 | $-3,635 | $2,918 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,452 | -6,504 | -5,998 | -3,450 | -3,561 |
| Capital Expenditure | -539 | -957 | -836 | -211 | -80 |
| Free Cash Flow | -8,991 | -7,461 | -6,835 | -3,661 | -3,641 |